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Abstract 
This study investigated the in vitro nail permeability of penetrants of varying 
lipophilicity—caffeine (CF, log P −0.07), methylparaben (MP, log P 1.96) and terbinafine 
(TBF, log P 3.3) and the effect of 2 novel penetration enhancers (PEs), thioglycolic acid 
(TA) and urea hydrogen peroxide (urea H2O2) on their permeation. Studies were 
conducted using full thickness human nail clippings and ChubTur® diffusion cells and 
penetrants were applied as saturated solutions. The rank order of steady-state 
penetrant flux through nails without PE application(MP > CF > TBF) suggesteda greater 
sensitivity to penetrant molecular weight rather than log P. TA increased the flux of CF 
and MP ∼4- and ∼2-fold, respectively, whilst urea H2O2 proved ineffective at enhancing 
permeability. The sequential application of TA followed by urea H2O2 increased TBF 
and CF flux (∼19- and ∼4-fold, respectively) but reversing the application order of the 
PEs was only mildly effective at increasing just MP flux (∼2-fold). Both nail PEs are 
likely to function via disruption of keratin disulphide bonds and the associated formation 
of pores that provide more ‘open’ drug transport channels. Effects of the PEs were 
penetrant specific, but the use of a reducing agent (TA) followed by an oxidising agent 
(urea H2O2) dramatically improved human nail penetration.  
 
1. Introduction 
The human nail plate is the most prominent part of the nail structure. It functions to 
protect the tips of the fingers and enables tasks such as the manipulation of small 
objects and scratching. The packing of dead, cornified cells in the nail plate gives rise to 
distinct dorsal, intermediate and ventral layers. The thickness of these layers varies 
between individuals, but the whole nail is generally between 0.5 and 1.0mm thick. It is 
composed of _-keratin, which provides structural rigidity, lipid and water (Gupchup and 
Zatz, 1999).  
The human nail is an excellent barrier against the ingress of foreign material, but as a 
consequence it also prevents effective topical treatment of ungual disorders such as 
onychomycosis (Einarson et al., 1996; Elewski, 1998; Seebacher, 2003). When 
infection resides in the nail plate, nail bed, or both, therapeutic antimicrobial drug 
concentrations must be achieved in the nail bed for treatment to be effective (Elewski, 
1998). However, this is difficult to achieve because the permeation of agents into the 
nail is low. Permeation occurs via passive diffusion with the rate determined by the 
physicochemical properties of the compound. Unfortunately, the most efficacious 
treatments for nail disorders do not penetrate the nail plate in sufficient amounts to be 
clinically effective (vanHoogdalem et al., 1997; Traynor et al., 2008).  
The poor clinical response to topical formulations has resulted in oral dosing remaining 
first-line therapy for many ungual disorders. However, oral treatment regimens can take 
months to be effective because they require large amounts of the drug to be loaded into 
the systemic circulation in order to achieve a local therapeutic concentration in the nail 
bed. Furthermore, systemic therapy may be contraindicated and has the potential for 
side-effects. For example, the oral antifungal agent terbinafine, which is used for  the 
treatment of onychomycosis can cause serious hepatotoxic side-effects and patients 
require continuous monitoring for the duration of the therapy (Chambers et al., 2001; Ajit 
et al., 2003). The inadequacies of the current treatments mean that there is still a 
requirement to develop an effective topical treatment for ungual disorders that will allow 
site-specific administration and minimise the systemic exposure of the therapeutic 
agent.  
To date, strategies employed to increase the permeation of therapeutic agents across 
the nail plate can be categorised into mechanical or chemical methods. Mechanical 
methods can be effective, but often involve damage or partial removal of the nail plate. 
Kobayashi et al. (1999) showed that removal of the dorsal layer of the nail plate before 
drug application increased the ungula permeation of a compound irrespective of 
itswater solubility.However, patient compliance tends to be low when such aggressive 
methods are used as part of topical antifungal therapy (Grover et al., 2007).  
Chemical methods of nail penetration enhancement involve the use of penetration 
enhancers (PEs) and numerous studies have demonstrated the effectiveness of PEs in 
vitro. Sulfhydryl (SHcontaining) compounds have been used to increase itraconazole 
uptake by the nail and acetylcysteine has been used to increase the ungual retention of 
miconazole nitrate (Sun et al., 1999). Dimethylsulfoxide enhances the delivery of 
ketaconazole and salicylic acid (Hui et al., 2002), and 2-mercaptopyridine-1-oxide, N-(2-
mercaptopropionyl) glycine (Malhotra and Zatz, 2002) and 2- n-nonyl-1,3-dioxolane 
(SEPA®) (Hui et al., 2003) are also reported to be effective PEs. Few, if any, of these 
agents, however, have been used in commercial products and very little information is 
available on the mechanism by which they function. One exception is thioglycolic acid 
(TA) which has been shown to disrupt the disulphide bond network of hair keratin 
(Olsen, 1999). Recent work has postulated that ungual keratin disruption caused by the 
application of TA leads to elevated levels of nail swelling. In addition, caffeine 
permeability experiments have demonstrated that pretreating nail samples with TA 
increases ungual drug flux (Khengar et al., 2007).  
One reason why ungual PEs have not been comprehensively and systematically 
investigated previously is the lack of appropriate in vitro assessment methods. Many of 
the current methods employed to investigate permeation through the nail are time 
consuming or difficult to perform and the generation of significant data can take weeks 
or months. However, a novel nail diffusion model (the ChubTur® cell) has been 
developed by MedPharm Ltd. (Guildford, UK) that allows the assessment of nail 
penetration using 3mm×3mm distal nail clippings (Khengar et al., 2007). The ChubTur® 
model, specifically designed for monitoring the in vitro ungual permeation and 
deposition of topically applied drugs, solves in part, the problems associated with 
existing in vitro models as it requires a relatively modest sample size and thus facilitates 
the use of human nail material over animal derived substitutes even though the latter 
are usually more readily available. The ChubTur® system therefore allows the 
investigation of ungual delivery under an environment that closely mimics the in vivo 
situation.  
In the present study the ChubTur® cell was utilised to determine the influence of log P 
on flux through healthy human nails and to investigate the effectiveness of TA and urea 
hydrogen peroxide (urea H2O2) at enhancing ungual flux. An additional objective was to 
confirm whether enhanced ungual flux could be further improved by sequentially pre-
treating nail samples with both PEs and whether the PE pre-treatment order influenced 
any additive or synergistic effects by altering the order of PE application. The final 
objective of the present study was to seek to identify if any of the PE effects were drug 
specific. Three permeants were selected for the present study. Two were model 
penetrants caffeine (CF) (log P −0.07 MWt 194) and methylparaben (MP) (log P 1.96 
MWt 152), and the third was a relevant therapeutic agent, terbinafine hydrochloride 
(TBF) (log P 3.3 MWt 328) an antifungal allylamine which is used in the treatment of 
onychomycosis. Although the permeating compounds were not of identical molecular 
weight (due in part to their contrasting lipophilicities), it was anticipated that the 
influence of this variantwould be relatively minor compared to that of the permeant 
partition coefficient. The two PEs used in this study were selected on the basis of 
previous investigations which demonstrated their potential application as ungual PEs 
(Khengar et al., 2007). The first PE was TA, a sulfhydryl-containing compound, and a 
well characterised reducing agent (Anfinsen and Haber, 1961; Kuzuhara and Hori, 
2003). The second PE was urea H2O2, a strong oxidising agent shown to increase nail 
swellability in a similar manner to TA (Khengar et al., 2007), and is currently utilised 
commercially by the hair care industry and also forms part of some tooth bleaching 
products (Wickett, 1987; Li, 1996). It is anticipated that insights into nail permeation 
enhancement will allowthe subsequent rational design of a clinically effective topical 
formulation for the treatment of ungual disorders such as onychomycosis. 
 
2. Materials and methods 
2.1. Materials 
Human nail clippings were donated from healthy volunteers following approval by the 
King’s College Research Ethics Committee (Study ref no. 04/05-126). Calibrated 
ChubTur® permeation cells were kindly donated by MedPharm Ltd. TA, urea H2O2, 
caffeine and methylparaben were purchased from Sigma–Aldrich (Dorset, UK). 
Phosphate buffered saline (PBS) (0.15 M, pH 7.3) was from Oxoid (Hampshire, UK). 
Ethanol (EtOH) was purchased from BDH Chemicals Ltd. (Dorset, UK). Scintillation fluid 
(hionic fluor) was supplied by PerkinElmer (Bucks, UK). Tritiated water (3H2O) was 
purchased from Amersham Biosciences (Buckinghamshire, UK). Triethylamine, 
orthophosphoric acid, potassium dihydrogen orthophosphate (KH2PO4) and acetonitrile 
(ACN) were supplied by Fisher (Leicestershire, UK). Terbinafine hydrochloridewas 
supplied by QueMaCo Ltd. (Nottingham, UK). 
 
2.2. Permeation studies 
Human nail clippings obtained from 15 donors, aged between 18 and 65 years, were 
washed with 70% EtOH (v/v) then deionised water 3 times. They were allowed to dry 
overnight in an open Petri dish at room temperature after which theywere either used 
immediately or stored in a clean glass container at 4 ◦C. Nail clippings were mounted on 
to pre-calibrated ChubTur® cells, as described previously (Khengar et al., 2007). Nail 
sections (approximate size 3mm×3mm) were clamped and held in place between 
receiver and donor chambers. The dorsal nail surface area exposed to the donor 
chamber was 0.05cm2.  
The concentrations of the PEs used in this study were based on earlier work (Khengar 
et al., 2007). TA (5%, w/w) was prepared in 80:20 water/EtOH (v/v) solution. Urea H2O2 
solution was prepared in water (Millipore) such that the concentration of the H2O2 was 
17.5% or 15% (w/v) as required. If no PE was applied, 80:20 water/EtOH (v/v) was used 
to hydrate the nails over 20 h (there was no significant increase in nail hydration beyond 
this time, data not shown). When applying a single PE, either 5% TA (w/w) or urea 
H2O2 solution was applied (0.5 ml) to the donor compartment of the ChubTur® cell so 
that the dorsal surface of the nail was submerged. Following a period of 20 h, the PE 
solution was removed and the donor compartment was flooded with deionised water to 
wash away any residual PE. The deionisedwaterwas then removed afterwhich 
thewashing stepwas repeated a further two times with fresh deionised water.  Any 
remaining moisture was removed using a dry tissue towel. If nails were to be treated 
with more than one PE, the second PE (either 5% TA (w/w) or urea H2O2 solution) was 
applied in the sameway again for 20 h, following the removal of the first PE and washing 
procedure. The second PE was again washed out of the donor chamber and any 
excess solution was removed using tissue towels. The receiver compartments of each 
cell were then filled to the calibration mark with the relevant receiver fluid; for CF 
thiswas PBS, forMP thiswas 80:20 PBS/EtOH (v/v) and for TBF the receiver fluid was 
50:50 PBS/EtOH (v/v) to maintain sink conditions throughout the experiment (PBS was 
0.15M and pH 7.3). The stability of the compounds in the relevant receiver fluid was 
confirmed over a period of 30 days (data not shown). Penetrant solutions were applied 
(0.5 ml) to the dry clean donor compartment after the application of the PEs or vehicle 
control. Penetrants were prepared and used at a saturated concentration to maintain a 
constant thermodynamic activity. Saturated solutions of CF, MP and TBF in PBS, 80:20 
PBS/EtOH and 50:50 PBS/EtOH, respectively, were prepared by adding an excess of 
solid compound to solvents (20 ml) and stirring until saturation was achieved 
(determined by HPLC) followed by filtering using a 0.45_msyringe filter (Nalgene, 
Hereford, UK) at room temperature. The diffusion cells were sealed with parafilm for the 
duration of the experiment to prevent evaporation and incubated in a water bath 
maintained at 32 ◦C in order to keep the enclosed dorsal nail surface temperature at 
approximately 28 ◦C (verified using a k-type insulated wire probe (Hanna Instruments, 
Bedfordshire, UK)) the temperature of the extremities such as fingers and toes in 
human beings under normal conditions (Maddock and Coller, 1933). 
 
2.3. Diffusion cell integrity verification 
Following each permeation study, an integrity check was performed using 3H2O as a 
well characterised permeability marker. The donor compartments of cells were washed 
by flooding with deionised water 3 times and then dried using clean tissue towels. 3H2O 
(3.7 Bq/ml) was applied to the donor chamber of each cell after replacing the fluid in the 
receiver chamber with deionised water. Samples (1 ml) were removed from the receiver 
chambers of cells after 1 h and 20 h and were aliquoted directly into scintillation vials to 
which 4 ml of scintillation fluid was added. The vials were closed, mixed thoroughly by 
shaking and analysed using a LS 6500 Multipurpose scintillation counter (Beckman 
CoulterTM, Buckinghamshire, UK). Radioactivity was quantified as disintegrations per 
minute (DPM) which are independent of quenching effects observed in liquid scintillation 
(Cammen, 1977). Cellswere rejected if total DPM at 1 h were on average more than 
20% higher than the mean of the other cells that had undergone the same pre-treatment 
or if the total DPM at 20 h was on average more than 40% higher than the mean of the 
other cells that had undergone the same pretreatment. These valueswere used 
aswewould not expect nail drug diffusion variability to exceed 20% after 1 h or 40% after 
20 h when a varied nail sample pool is utilised (Khengar et al., 2007). 
 
2.4. Data analysis 
Cumulative amounts of compound (_g) penetrating the nail per surface area (cm2)were 
corrected for previous sample removal and plotted against time (h). The slope of the 
linear portion of the permeation rate profile (R2 ≥0.95) was estimated as the steady-
state flux (Js) of penetrant permeation. Lag time was derived from the x intercept of the 
slope at steady state. Enhancement ratio (ER) was calculated using equation (1): 
ER = Js(E)/ Js(C)           (1) 
where Js(E) and Js(C) are the flux values of the penetrant following pre-treatment with 
enhancer or control (no pre-treatment),respectively. Results were expressed as the 
mean±standard deviation (SD) of 3–8 determinations.  
 
A one-way ANOVA was used for statistical analysis of variance and differences were 
further evaluated for significance with a post hoc Tukeymeans comparisons test. A level 
of P≤0.05 was considered significant. 
 
2.5. HPLC analysis 
A series 200 LC pump with autosampler and vacuum degasser connected to a UV/Vis 
detector 785A (PerkinElmer, Bucks, UK) was used for analytical determination of CF 
and MP. This system was connected, via a Nelson network chromatography interface 
(NCI) 900 and Nelson 600 Series LINK to a PC with Turbochrome Navigation software 
(PerkinElmer, Bucks, UK) for data collection and interpretation. For the analysis of TBF, 
a Waters 2487 dual _ absorbance detector, 600 controller, 717 plus autosampler, and 
Millennium32 Chromatograph Manager Software were used. HPLC analysis parameters 
are detailed in Table 1. Analysis of CF and MP was adapted from the method described 
by Akomeah et al. (2004) and the method for TBF was based on that described by 
Denouel et al. (1995). The HPLC methods were deemed to be fit for purpose upon 
assessment of linearity, precision, accuracy and asymmetry according to the current 
ICH guidelines (ICH Q2A 1995; ICH Q2B 1997). 
 
3. Results 
3.1. Permeability through untreated nails 
The in vitro flux (at steady-state) of the 3 penetrants through nails that were not treated 
with the PEs were significantly different (P≤0.05, ANOVA) and ranked MP> CF > TBF 
(Figs. 1–3). The rate of MP flux was approximately 3-fold and 11-fold greater than that 
of CF and TBF, respectively. The rate of CF ungual flux was around 7 times greater 
compared to the flux of TBF. The mean lag times calculated for each penetrant, i.e. the 
time taken to reach steady-state permeation,were inversely related to their permeability 
(MP≤CF < TBF) but the difference between MP and CF was not significant (P > 0.05). 
 
3.2. Permeability following single PE application 
The flux of the 3 penetrants was influenced to different extents as a result of nail pre-
treatment with the PEs (as reflected by the ER values, Table 2). Pre-treating nails with 
TA alone significantly enhanced (P < 0.05) the ungual flux of CF and MP (Figs. 1 and 2) 
whilst the increase in TBF permeation (Fig. 3) was not significant (P > 0.05). When urea 
H2O2 was applied as the sole PE, the flux of all 3 penetrants were statistically 
equivalent (P > 0.05) to their respective flux through untreated nails. The lag time for all 
penetrants was effectively reduced as a result of TA pre-treatment, whereas no 
significant decreases (P > 0.05) were observed when 
urea H2O2 was the PE.  
 
 
Table 1 HPLC parameters for analysis of caffeine (CF), methylparaben (MP) and 
terbinafine hydrochloride (TBF). 























Injection volume 50 µl 20 µl 40 µl 
Mobile phase 
composition 
92:8 80:20 60:40 
92% (0.05 M 
KH2PO4; 1% 
triethylamine; 
pH 3.5) 8% 
acetonitrile 
80% (0.05 M 
KH2PO4; 1% 
triethylamine; 






acid buffer; pH 2), 
40% acetonitrile 
 
Flow rate 1 ml/min 1ml/min 0.3 ml/min 
 
Run time 20 min 15 min  
 
10 min 
Detection λ=275nm λ=254 nm λ=224nm 
 
 
 Fig. 1. Permeation profiles of caffeine following pre-treatment with single and sequential 
penetration enhancing systems. Single treatment consisted of 20 h pretreatment with 
either thioglycolic acid (TA) (_) or urea hydrogen peroxide (urea H2O2) (_). Sequential 
treatment systems were 20 h TA pre-treatment followed by 20h urea H2O2 (_) and 20 h 
urea H2O2 pre-treatment followed by 20 h TA pretreatment (×). Control (_) represents 




Fig. 2. Permeation profiles of methylparaben following pre-treatment with single and 
sequential penetration enhancing systems. Single treatment consisted of 20 h pre-
treatment with either thioglycolic acid (TA) (_) or urea hydrogen peroxide (urea H2O2) 
(_). Sequential treatment systemswere either 20 h TApre-treatment followed by 20 h 
urea H2O2 (_) or 20 h urea H2O2 pre-treatment followed by 20 h TA pretreatment (×). 





Fig. 3. Permeation profiles of terbinafine hydrochloride following pre-treatment 
with single and sequential enhancing systems. Single treatment consisted of 20 h 
pre-treatment with either thioglycolic acid (TA) (_) or urea hydrogen peroxide (urea 
H2O2) (_). Sequential treatment systems were either 20 h TA pre-treatment followed 
by 20 h urea H2O2 (_) or urea H2O2 20 h pre-treatment followed by 20 h TA 
pre-treatment (×) (the data for this is not easily visible on the graph as the results 
overlap with control data). Control (_) represents no penetration enhancer (n = 6–8, 
mean±SD). 
 
Table 2 The flux rates (µgcm−2 h−1, mean±SD) of caffeine (CF), methylparaben (MP) 
andterbinafine hydrochloride (TBF) through nails pre-treated with thioglycolic acid (TA) 
and urea hydrogen peroxide (urea H2O2) as part of the single or sequential 





Flux (µgcm−2 h−1) Lag time (h) ER 
CF None  3.64 ± 1.54  70.70 ± 34.29  – 
 5% TA  14.10 ± 3.42*  10.71 ± 10.63  3.87 
 15% Urea H2O2  8.45 ± 3.76  52.64 ± 20.25 - 
 5% TA followed by 
15% Urea H2O2 
14.16 ± 4.98*  23.57 ± 10.59 3.89 
 
 15% Urea H2O2 
followed 5% TA 
3.76 ± 2.24 45.45 ± 16.87  
 
– 
MP None  6.05 ± 1.48  50.38 ± 3.36 – 
 5% TA  12.51 ± 4.29*  29.65 ± 3.55  2.07 
 15% Urea H2O2  9.27 ± 1.93  42.31 ± 5.47  – 
 5% TA followed by 
15% Urea H2O2 
9.72 ± 6.36 37.25 ± 13.10  – 
 
 15% Urea H2O2 
followed 5% TA 
12.17 ± 2.98*  
 
37.74 ± 3.76  2.01 
TBF None  0.55 ± 0.71  121.39 ± 14.13  – 
 5% TA  4.73 ± 1.01  33.62 ± 14.74  – 
 17.5% Urea H2O2  0.43 ± 0.29  113.33 ± 10.64  – 
 5% TA followed by 
17.5% Urea H2O2 
10.22 ± 5.22*  26.91 ± 27.16 18.67 
 
 17.5% Urea H2O2 
followed by 5% TA 
1.25 ± 0.80  53.93 ± 22.81  – 
 
 
Flux derived from linear plot (R2 ≥0.95). 
Enhancement ratios (ER) are only given where penetrant flux increase was significant 
(P≤0.05) compared to untreated nails. 
* Increase is significant when compared to the control value. 
 
3.3. Application of both PEs in sequence and the effect of application order 
The flux of 2 of the 3 penetrants (CF and TBF) was significantly higher (P < 0.05) 
through nails pre-treated with TA followed by urea H2O2 compared to untreated nails. 
The increase in TBF permeation resulted in the highest observed penetrant flux 
increase (ER = 18.67). The time taken for steady-state flux to be achieved however was 
significantly decreased for all penetrants as a result of this sequential pre-treatment 
regime. In addition, the rate of TBF fluxwas significantly greater (P < 0.05) across nails 
pre-treated with TA followed by urea H2O2 compared to TA-only pre-treated nails 
(approximately double).  
Reversing the application order of the PEs (pre-treating with urea H2O2 first and TA 
second) showed considerable differences in the flux enhancement of all 3 penetrants. 
The flux of MP alone was significantly higher (P < 0.05) across nails pre-treated with 
urea H2O2 followed by TA compared to untreated nails, but the increased rate of MP 
permeation was not significantly greater (P > 0.05) than the enhanced MP flux through 
TA-only pre-treated nails. Significant reductions in lag times were however observed for 
MP and TBF when nails were pre-treated with urea H2O2 followed by TA (a reduction of 
25% and 78%, respectively). 
 
4. Discussion 
The human nail plate is composed of three compacted keratinized epithelial cell layers 
(the dorsal, intermediate and ventral) (Lewis, 1954;Dawber, 1980; Gupchup et al., 
1999). As an adsorption barrier the nail has been simplistically described in the 
literature as a hydrophilic gelmembrane (Mertin and Lippold, 1997b; Kobayashi et al., 
1999) that effectively obstructs drug permeation by virtue of its chemical composition 
(Gniadecka et al., 1998). Extensive folding of the ‘hard’ keratin protein chains of the nail 
aremaintained by extremely stable disulphide bonds whichcan bemodifiedusing 
oxidizing or reducing conditions. Disruption of these disulphide bonds is hypothesised to 
compromise the structure of proteins that have a high proportion of disulphide cross-
links. This theory has already been exploited by the cosmetics industry to produce hair 
straightening and waving agents (disulphide bond reduction and oxidation) (Wortmann, 
1994; Robbins, 2002) and depilatory products (disulphide reduction) (Liew, 1999). 
Permeation through the nail is generally believed to be influenced by the 
physicochemical properties of the penetrating molecule. Nail permeability has been 
previously been reported to be especially sensitive to the lipophilicity of a drug (Walters 
et al., 1983;Kobayashi et al., 1999). In the present study, the permeation of three 
compounds that differed considerably in terms of lipophilicity was investigated—CF, (log 
P −0.07, MWt 194), MP (log P 1.96, MWt 152), and TBF (log P 3.3, MWt 328). The rank 
order of in vitro penetrant permeation through nails that were not pre-treated with PEs 
however, displayed an inverse correlation to molecular weight rather than log P. This 
finding may indicate that the molecular weight of acompound traversing the nail plate 
has greater influence than its lipophilicity in determining the extent of its permeation. 
The present study therefore, supports previous claims that molecular weight is the 
critical physicochemical property in ungual drug permeation (Mertin and Lippold, 1997a; 
Kobayashi et al., 2004) and proposes that the gel membrane description commonly 
given to the nail is overly simplistic and that nail barrier properties might be better 
likened to that of a more complex compact, hydrophilic filter. 
An alternative explanation for the permeation rank order of the 3 penetrants through 
untreated nails is that drug retention or binding in the nail keratin matrix occurred after 
drug penetration. The retention of various drugs by skin is well documented (Hashiguchi 
et al., 1998; Akomeah et al., 2004), for example polar drugs such as doxycycline are 
reported to bind to skin keratin via hydrogen bonds (Banning and Heard, 2002). 
Similarly, for the nail, there are reports that antifungal agents including TBF have a 
strong binding affinity for keratin (Tatsumi et al., 2002). It is possible therefore, that the 
ungual flux of CF,MP and TBF through untreated nails demonstrate the extent of drug 
binding in addition to the influence of penetrant MW and log P. 
The nature of the application vehicle in which the penetrating drug is dissolved has also 
previously been reported to effect ungual permeability. Aqueous vehicles have been 
shown to facilitate drug transport across the nail by enhancing nail swelling which 
presumably results in greater drug mobility in the barrier and perhaps the formation of 
pores (Murdan, 2002). The hydration state of the nail therefore, is undoubtedly an 
important factor in compound flux, and has been demonstrated by numerous 
researchers (Wessel et al., 1999; Gunt and Kasting, 2007). Due to their contrasting 
solubilities, each of the applied penetrants used in the present study were solubilised in 
vehicles that differed in their aqueous and ethanolic content (CF–PBS, MP–80:20 
PBS:EtOH, v/v and TBF–50:50 PBS:EtOH, v/v). In addition, to ensure sink conditions 
were maintained during the permeation experiments the receiver fluids for each 
permeation study was matched to respective application solvent. Ethanol enhances the 
skin permeation of topically applied agents (Megrab et al., 1995; Stinecipher and Shah, 
1997) by modifying the lipid domains of the stratum corneum (Bommannan et al., 
1991;Williams, 2003). As the lipid content of the nail is considerably less than skin (the 
dorsal nail layer contains only ∼0.1% lipid compared to ∼20% in skin) the necessity of 
having to use different PBS/ethanol mixtures in the permeation studies of the current 
investigation was anticipated to have little or no effect on ungula penetrant mass 
transfer. This postulation is supported by previous studies which confirm that the 
swelling behaviour, and hence the hydration state of the nail is not significantly different 
(P > 0.05, ANOVA) in mixed ethanol/aqueous solvents consisting of 0%, 20% and 50% 
ethanol (Khengar et al., 2007). Therefore, whilst aqueous vehicles clearly assist ungual 
permeation, the penetrating enhancing ability of ethanol is likely to be absent in the nail 
at the levels used in this study, despite its ability to act as a dermal enhancer. 
The use of chemical nail penetration enhancers to deliver therapeutically relevant 
concentrations of drugs to the nail unit has recently received considerable interest 
(vanHoogdalem et al., 1997; Hui et al., 2003; Mohorcic et al., 2007; Khengar et al., 
2007; Hao et al., 2008), largely due to the ineffective penetration of topically applied 
antimycotics through the nail plate. The present investigation considered the potential of 
TA and urea H2O2 to enhance the ungual permeation of CF,MP and TBF as these two 
putative PEs have previously been shown to elevate nail hydration following a simple 
incubation protocol of the nail with the PE (Khengar et al., 2007). It was hypothesised 
that both PEs encourage nail swelling which leads to a structural expansion of the nail 
membrane. The chemical bond disruption facilitates the uptake of unexpectedly high 
quantities of water after PE application which was proposed to enhance drug mobility in 
the barrier. In the present study, TA successfully enhanced the ungual flux of CF and 
MP and reduced the lag times for all 3 penetrantswhilst urea H2O2 was less effective. 
TA and salts of TA are commonly used in depilatory products at a concentration of 5% 
(Olsen, 1999) and in hair waving or straightening products at concentrations between 8 
and 11%. Likewise, urea H2O2 is a component of some tooth bleaching formulations 
and concentrations used commercially vary between 10 and 35% (Li, 1996; Oltu and 
Gurgan, 2000). TA contains a thiol moiety that enables the chemical break down of 
disulphide linkages in hair and wool through a reduction process (Gupchup et al., 1999). 
Due to the similarities in the amino acid profiles of hair, wool and nail (Robbins, 2002) it 
is logical to hypothesise that a similar redox reaction involving nail disulphide bond 
reduction by TA compromised the rigidity of the ungual barrier, permitting an 
improvement in the rate of CF and MP flux. In contrast to TA, urea H2O2 is an oxidising 
agent, and as a hydrogen-bonded adduct it is reported to be more stable thanH2O2 
alone (Gonsalves et al., 1991). Although disulphide oxidation is possible in the presence 
of excess oxidant (Capozzi and Modena, 1974), there have been, to our knowledge, no 
reports of oxidising agents influencing the barrier properties of the human nail. In this 
study, pre-treating nails with urea H2O2 did not increase the permeation of CF, MP or 
TBF, perhaps due to the marked stability of the disulphide bond against oxidation in 
comparison to its reactivity with the thiol group (Capozzi and Modena, 1974; Gilbert, 
1995). 
The reduction of disulphide bonds is a reversible process and broken disulphide 
linkages can be reformed using an oxidizing agent (Wickett, 1987); a fact that suggests 
that applying an oxidizing agent to the nail directly after a reducing agent would be 
ineffective at enhancing ungual permeability and might instead restore barrier function. 
However, in the present study permeation of 2 of the 3 penetrants was increased as a 
result of applying the PEs in sequence; CF and TBF permeation clearly improved when 
nails were pre-treated with TA followed by urea H2O2 (∼4- and 19-fold, respectively). 
This could be explained by the relatively high concentration of urea H2O2 applied to the 
nail as typically, only 2–3% solutions of H2O2 are used to reinstate reduced disulphide 
links in human and sheep hair (Marshall et al., 1991; Robbins, 2002), whilst a much 
higher concentration of 15 or 17.5% was applied to nails in the current investigation. In 
addition, the reformation of broken disulphide bonds in human hair is reported to be only 
85–95% efficient (Cannell, 1988), and is believed to be accompanied by the formation 
of mixed disulphide bonds or cysteic acid. An excess of urea H2O2 remaining in the nail 
following its application may promote the oxidation of mixed disulphides or even, as 
previously reported, lead to an oxidation cascade starting with disulphide bond 
reformation followed by the sequential production of thiosulfinates, thiosulfonates and 
ultimately sulfonic acids (Capozzi and Modena, 1974). 
The selection of TBF as a model penetrant in the present study was anticipated to 
illustrate the permeability potential of this lipophilic drug through the nail compared to 
drugs of contrasting log P and in addition, to directly assess whether the delivery of this 
relevant therapeutic antifungal compound through the nail could be enhanced. Excellent 
retention of TBF has been reported in human and animal fat tissues in clinical 
pharmacokinetic studies, reflecting the high lipophilicity of this drug (Jensen, 1989). 
Based on the hydrophilic-like nature of the nail membrane (Walters et al., 1983;Walters, 
1985; Kobayashi et al., 1999) and the low lipid content of the nail, TBFwould be 
expected to permeate the nail poorly. In the present study however, the steady-state 
flux of TBF was enhanced to the greatest extent following nail pre-treatment with TA 
followed by urea H2O2, the rate being comparable to the highest observed flux of the 
study (flux of hydrophilic CF after the same pre-treatment, Table 2). This surprising 
result might be explained by the expanded, ‘swollen’ nail keratin network induced by PE 
pretreatment which may have facilitated TBF permeation. Although pre-treated swollen 
nails would be likely to have a hydrophilic internal environment, it is proposed that using 
a mixed aqueous/ ethanolic solvent for TBF studies (50:50) facilitated partitioning of this 
drug whilst still having a high enough content of aqueous matter to maintain the 
increased open pore state of the nail. Whilst this is a logical hypothesis, this data clearly 
raises important questions about nail permeability and nail biochemistry in general and 
these issues warrant further investigation. 
MP was the only penetrant to see increased permeation when the PEs were applied in 
the reverse sequence (urea H2O2 followed by TA), and although it is at present unclear 
why this was the case, this finding demonstrates that the effectiveness of the sequential 
pre-treatment regime is compound-specific and the need to confirm the efficacy of the 
pre-treatment with respect to a relevant therapeutic molecule prior to its incorporation 
into a topical ungula formulation. 
 
5. Conclusions 
Nail PE systems consisting of TA and urea H2O2 were tested for their effectiveness at 
enhancing the permeation of 3 model penetrants with a range of lipophilicity. The 
permeation enhancement of each penetrant following PE treatment was compound 
specific and the most effective enhancement was for TBF permeation which resulted 
from sequential treatment of nails with TA followed by urea H2O2. The data presented 
herein demonstrates the potential use of such PE systems with TBF in the topical 
treatment of onychomycosis. Whilst the concentrations of the PEs in the present study 
were moderately high, further studies will clarify the minimum concentrations required 
for effective permeation enhancement. The pre-treatment durations reported in this 
study were also considerably long (20 h) but again it is anticipated that future 
optimisation and formulation of the PEs will lead to lower pre-treatment times which will 
be more suitable for clinical settings and hence patient treatment. 
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